IMA Analyst Ratings & Price Targets

IMAIMA

|||

Overview Charts News Fundamentals Key Metrics TTM Financials Earnings Growth Rating Analysts Institutional Peers Historical

Analyst Sentiment

Analysts lean bullish — 80% recommend buying.

Consensus Rating

Buy

5 analysts·Limited coverage

80%

Rating Distribution

Strong Buy

00%

Buy

480%

Hold

120%

Sell

00%

Strong Sell

00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Current price is 81% above analyst consensus — significant downside expected.

Bear Case

$1.33

-81%

Consensus

$1.33

-81%

Bull Case

$1.33

+-81%

Price Range5 analysts

Low

Consensus

High

$1.33

Current Target

Current Price

$7.00

Above Target

$5.67

Price targets are 12-month forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

2026E$-4.01(2 analysts)

Actual

Estimate

Range (Low–High)

Stock Alarm Pro

Forward Growth Estimates (YoY)

FY2027

Rev-13.18%

EPS—

FY2028

Rev-13.18%

EPS—

FY2029

Rev-13.18%

EPS—

Earnings Surprises

Beat rate:83%(10/12 quarters)

Avg surprise:+9.2%

Beat

Miss

Inline

Estimate

Based on reported EPS vs consensus estimate.

Recent Analyst Actions

May 29, 2024Wedbush

This American Airlines Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday

Target:$1.33

-18.9%from $1.64

May 29, 2024Wedbush

iKena Oncology downgraded to Neutral from Outperform at Wedbush

Target:$2.00

+50.4%from $1.33

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance